REPORT HIGHLIGHT
The global hypertriglyceridemia market was valued at USD 9.82 billion by 2019, growing with 5.6% CAGR during the forecast period, 2021-2027.
Hypertriglyceridemia is a disorder in which triglyceride levels are elevated. Elevated triglycerides are determined by direct laboratory analysis of plasma or serum after a 10- to 12-hour fast. It is mainly caused by uncontrolled obesity, diabetes mellitus, and sedentary habits. It is more prevalent in the United States and in industrialized societies than in emerging nations. The growing prevalence of peripheral artery disease (PAD) and coronary artery disease (CAD) is likely to boost the growth of the global hypertriglyceridemia market. For instance, according to the American College of Cardiology, coronary artery disease (CAD) estimates for the highest cause of morbidity and mortality in the U.S. More than 42 percent of patients with CAD also have peripheral artery disease (PAD). Additionally, unhealthy lifestyles and increased cases of atherogenic dyslipidemia are anticipated to support the expansion of the overall hypertriglyceridemia market in the near future.
Furthermore, growth in the geriatric visits in ASC and outpatient facilities is estimated to account for the robust growth of the hypertriglyceridemia market in the upcoming years. On the other hand, strategies undertaken by the leading manufacturer to develop and launch more advanced hypertriglyceridemia therapeutics is projected to create significant growth opportunities for the market in the near future. For instance, in November 2020, Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, launched Icosapent Ethyl Capsules, 1gm, in the US. This Hikma's FDA-approved Icosapent Ethyl Capsule product is indicated to reduce triglyceride levels in adult patients with severe (≥500 mg/dL) hypertriglyceridemia. Further, in March 2020, Zydus Cadila gets the DCGI nod for Saroglitazar to treat liver disease. Saroglitazar was launched in September 2013 in India, for the treatment of hypertriglyceridemia and diabetic dyslipidemia. In addition, in September 2020, 89bio, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases announced the initiation of a Phase 2 trial evaluating its product candidate BIO89-100 in patients with severe hypertriglyceridemia. BIO89-100 is a glycoPEGylated analog of fibroblast growth factor 21 ("FGF21") in clinical development for the treatment of non-alcoholic steatohepatitis ("NASH") and SHTG.
However, unfavourable reimbursement scenario and the high cost of hypertriglyceridemia therapeutics is predicted to hamper the growth of the target market. Moreover, the lack of medical care in developing economies might also sluggish the growth of the business market. Geographically, North America dominates the hypertriglyceridemia market in terms of the highest revenue share. The backside is mainly attributed because of the availability of higher antibiotics and advancement in drug designing. Besides, rising awareness about antibiotic-associated conditions, higher adoption of junk foods, and an increase in hospital-acquired infection awareness coupled with the supporting regulatory policies have enhanced the monitoring scenario for the North American hypertriglyceridemia market.
Key features of the study:
- This proposed research study on Hypertriglyceridemia market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2020-2027), considering 2019 as the base year
- The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Hypertriglyceridemia market
- The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Hypertriglyceridemia market
- Impact of COVID-19 on Hypertriglyceridemia market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Hypertriglyceridemia market post-COVID will also be covered.
- In order to give the users of this report a comprehensive view on the Hypertriglyceridemia market, we have also included competitive landscape and key innovator analysis for the Hypertriglyceridemia market.
- The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and Treatment's attractiveness.
- The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Hypertriglyceridemia market.
- In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new product launch, research & development, regional expansion of major participants involved in the Hypertriglyceridemia market on global as well as regional level.
- The global Hypertriglyceridemia market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL HYPERTRIGLYCERIDEMIA MARKET KEY PLAYERS
- Sanofi
- GlaxoSmithKline Plc
- Biocon
- Novo Nordisk A/S
- Tonghua Dongbao Pharmaceutical Co., Ltd.
- Oramed Pharmaceuticals, Inc.
- Bristol-Myers Squibb Company
- Merck & Co., Inc.
- Julphar
- Eli Lilly and Company
- Pfizer Inc.
- Adocia
- Hikma Pharmaceutical PLC
- Lupin Ltd.
- Wockhardt
- Zydus Pharmaceuticals Inc.
- AbbVie Inc.
- Glenmark
- Amneal pharmaceutical LLC
- Aurobindo Pharma
- Accord Healthcare
GLOBAL HYPERTRIGLYCERIDEMIA MARKET, BY TYPE
- Primary Hypertriglyceridemia
- Secondary Hypertriglyceridemia
- Others
GLOBAL HYPERTRIGLYCERIDEMIA MARKET, BY TREATMENT
- Pharmacological
- Fibrates
- Statins
- Niacin
- Other Lipid-Lowering Medications
- Non-Pharmacological
- Lifestyle Changes
- Dietary Modification
- Exercise
- Others
- Emerging Treatments
- Rimonabant
- Glitazar Drugs
- LPL Gene Therapy
- Others
- Others
GLOBAL HYPERTRIGLYCERIDEMIA MARKET, BY END-USER
- Hospitals
- Specialty Clinics
- Homecare
- Others
GLOBAL HYPERTRIGLYCERIDEMIA MARKET, BY DISTRIBUTION CHANNEL
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
GLOBAL HYPERTRIGLYCERIDEMIA MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Singapore
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Rest of MEA
Table of Contents
1. Hypertriglyceridemia Market Overview
Study Scope
2. Executive Summary
Market Snippet
Market Snippet by Type
Market Snippet by Treatment
Market Snippet by End-user
Market Snippet by Distribution Channel
Market Snippet by Region
Competitive Insights
3. Hypertriglyceridemia Key Market Trends
Market Drivers
Impact Analysis of Market Drivers
Market Restraints
Impact Analysis of Market Restraints
Market Opportunities
Market Future Trends
4. Hypertriglyceridemia Industry Study
Porter's Five Forces Analysis
Marketing Strategy Analysis
Growth Prospect Mapping
Regulatory Framework Analysis
5. Hypertriglyceridemia Market : COVID-19 Impact Analysis
Pre-COVID-19 Impact Analysis
Post-COVID-19 Impact Analysis
Top Performing Segments
Marginal Growth Segments
Top Looser Segments
Marginal Loss Segments
6. Hypertriglyceridemia Market Landscape
Market Share Analysis, 2019
Key Innovators Analysis
Breakdown Data, by Key Manufacturer
Established Players' Analysis
Emerging Players' Analysis
7. Hypertriglyceridemia Market - By Type
Overview
Segment Share Analysis, By Type, 2020 & 2027 (%)
Primary Hypertriglyceridemia
Secondary Hypertriglyceridemia
Others
8. Hypertriglyceridemia Market - By Treatment
Overview
Segment Share Analysis, By Treatment, 2020 & 2027 (%)
Pharmacological
Fibrates
Statins
Niacin
Other Lipid-Lowering Medications
Non-Pharmacological
Lifestyle Changes
Dietary Modification
Exercise
Others
Emerging Treatments
Rimonabant
Glitazar Drugs
LPL Gene Therapy
Others
Others
9. Hypertriglyceridemia Market - By End-user
Overview
Segment Share Analysis, By Treatment, 2020 & 2027 (%)
Hospitals
Specialty Clinics
Homecare
Others
10. Hypertriglyceridemia Market - By Distribution Channel
Overview
Segment Share Analysis, By Treatment, 2020 & 2027 (%)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
11. Hypertriglyceridemia Market - By Geography
Introduction
Segment Share Analysis, By Geography, 2020 & 2027 (%)
North America
Overview
Key Manufacturers in North America
North America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
North America Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
North America Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
North America Market Size and Forecast, By End-user, 2016 - 2027 (US$ Million)
North America Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
U.S.
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
U.S. Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
U.S. Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
U.S. Market Size and Forecast, By End-user, 2016 - 2027 (US$ Million)
U.S. Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
Canada
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
Canada Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
Canada Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
Canada Market Size and Forecast, By End-user, 2016 - 2027 (US$ Million)
Canada Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
Europe
Overview
Key Manufacturers in Europe
Europe Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
Europe Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
Europe Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
Europe Market Size and Forecast, By End-user, 2016 - 2027 (US$ Million)
Europe Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
Germany
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
Germany Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
Germany Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
Germany Market Size and Forecast, By End-user, 2016 - 2027 (US$ Million)
Germany Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
Italy
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
Italy Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
Italy Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
Italy Market Size and Forecast, By End-user, 2016 - 2027 (US$ Million)
Italy Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
United Kingdom
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
United Kingdom Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
United Kingdom Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
United Kingdom Market Size and Forecast, By End-user, 2016 - 2027 (US$ Million)
United Kingdom Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
France
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
France Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
France Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
France Market Size and Forecast, By End-user, 2016 - 2027 (US$ Million)
France Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
Rest of Europe
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
Rest of the Europe Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
Rest of the Europe Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
Rest of the Europe Market Size and Forecast, By End-user, 2016 - 2027 (US$ Million)
Rest of the Europe Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
Asia Pacific (APAC)
Overview
Key Manufacturers in Asia Pacific
Asia Pacific Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
Asia Pacific Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
Asia Pacific Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
Asia Pacific market Size and Forecast, By End-user, 2016 - 2027 (US$ Million)
Asia Pacific Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
India
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
India Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
India Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
India Market Size and Forecast, By End-user, 2016 - 2027 (US$ Million)
India Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
China
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
China Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
China Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
China Market Size and Forecast, By End-user, 2016 - 2027 (US$ Million)
China Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
Japan
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
Japan Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
Japan Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
Japan Market Size and Forecast, By End-user, 2016 - 2027 (US$ Million)
Japan Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
South Korea
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
South Korea Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
South Korea Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
South Korea Market Size and Forecast, By End-user, 2016 - 2027 (US$ Million)
South Korea Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
Rest of APAC
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
Rest of APAC Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
Rest of APAC Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
Rest of APAC Market Size and Forecast, By End-user, 2016 - 2027 (US$ Million)
Rest of APAC Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
Latin America
Overview
Key Manufacturers in Latin America
Latin America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
Latin America Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
Latin America Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
Latin America Market Size and Forecast, By End-user, 2016 - 2027 (US$ Million)
Latin America Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
Brazil
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
Brazil Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
Brazil Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
Brazil Market Size and Forecast, By End-user, 2016 - 2027 (US$ Million)
Brazil Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
Mexico
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
Mexico Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
Mexico Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
Mexico Market Size and Forecast, By End-user, 2016 - 2027 (US$ Million)
Mexico Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
Argentina
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
Argentina Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
Argentina Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
Argentina Market Size and Forecast, By End-user, 2016 - 2027 (US$ Million)
Argentina Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
Rest of LATAM
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
Rest of LATAM Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
Rest of LATAM Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
Rest of LATAM Market Size and Forecast, By End-user, 2016 - 2027 (US$ Million)
Rest of LATAM Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
Middle East and Africa
Overview
Key Manufacturers in Middle East and Africa
Middle East and Africa Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
Middle East and Africa Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
Middle East and Africa Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
Middle East and Africa Market Size and Forecast, By End-user, 2016 - 2027 (US$ Million)
Middle East and Africa Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
Saudi Arabia
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
Saudi Arabia Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
Saudi Arabia Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
Saudi Arabia Market Size and Forecast, By End-user, 2016 - 2027 (US$ Million)
Saudi Arabia Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
United Arab Emirates
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
United Arab Emirates Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
United Arab Emirates Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
United Arab Emirates Market Size and Forecast, By End-user, 2016 - 2027 (US$ Million)
United Arab Emirates Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
12. Key Vendor Analysis
Competitive Dashboard
Company Profiles( Companies are profiled based on attributes such as Company Overview, Financial Performance, Business Overview, Type Benchmarking and Strategic Developments)
Sanofi
GlaxoSmithKline Plc
Biocon
Novo Nordisk A/S
Tonghua Dongbao Pharmaceutical Co., Ltd.
Oramed Pharmaceuticals, Inc.
Bristol-Myers Squibb Company
Merck & Co., Inc.
Julphar
Eli Lilly and Company
Pfizer Inc.
Adocia
Hikma Pharmaceutical PLC
Lupin Ltd.
Wockhardt
Zydus Pharmaceuticals Inc.
AbbVie Inc.
Glenmark
Amneal pharmaceutical LLC
Aurobindo Pharma
Accord Healthcare
13. 360 Degree Analyst View
14. Appendix
Research Methodology
References
Abbreviations
Disclaimer
Contact Us
